Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Approach to immunization in the immunosuppressed host.

P L Hibberd1, R H Rubin

  • 1Harvard Medical School, Boston, Massachusetts.

Infectious Disease Clinics of North America
|March 1, 1990
PubMed
Summary

Immunocompromised patients need protection from infections. Future efforts should focus on developing immunoadjuvants to enhance vaccine effectiveness for these vulnerable populations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of haemoglobin levels in the first trimester and at 26-30 weeks with fetal and neonatal outcomes: a secondary analysis of the Global Network for Women's and Children's Health's ASPIRIN Trial.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Maternal anaemia and maternal, fetal, and neonatal outcomes in a prospective cohort study in India and Pakistan.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

A prospective cause of death classification system for maternal deaths in low and middle-income countries: results from the Global Network Maternal Newborn Health Registry.

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

Global Network for Women's and Children's Health Research: probable causes of stillbirth in low- and middle-income countries using a prospectively defined classification system.

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

Antibiotic-associated diarrhoea in emergency department observation unit patients.

Epidemiology and infection·2016
Same author

Travel medicine and transplant tourism in solid organ transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013

Area of Science:

  • Immunology
  • Infectious Diseases
  • Vaccinology

Background:

  • Growing population of immunocompromised individuals (e.g., AIDS patients, those with compromised host defenses due to disease or therapy) require infectious disease prophylaxis.
  • Existing vaccines offer some protection, but their efficacy in immunocompromised individuals is not guaranteed.
  • Adjunctive measures like antimicrobial prophylaxis and intravenous immunoglobulin are sometimes necessary.

Purpose of the Study:

  • To highlight the need for enhanced strategies to protect immunocompromised individuals from infectious diseases.
  • To emphasize the limitations of current vaccines in this population.
  • To advocate for future research and development in immunoadjuvants.

Main Methods:

  • Review of current prophylactic strategies for immunocompromised patients.
  • Discussion of the limitations of existing vaccines.
  • Exploration of potential future therapeutic avenues.

Main Results:

  • Vaccine response in immunocompromised individuals cannot be assumed.
  • Antimicrobial prophylaxis (e.g., amantadine, penicillin) and intravenous immunoglobulin are valuable adjunctive measures.
  • Development of new vaccines alone is insufficient.

Conclusions:

  • Immunocompromised patients require tailored infectious disease prophylaxis.
  • Immunoadjuvants represent a promising area for future vaccine development to improve efficacy in vulnerable populations.
  • A multi-faceted approach combining existing strategies and novel immunotherapies is essential.

Related Experiment Videos